BIO-Europe Spring® 2014 Kicks Off Next Week in Turin, Italy

  BIO-Europe Spring® 2014 Kicks Off Next Week in Turin, Italy

             Event is gathering of life science industry leaders

BIO-Europe Spring 2014

Business Wire

CARLSBAD, Calif. & NEW YORK & TURIN, Italy -- March 3, 2014

The eighth annual BIO-Europe Spring® conference kicks off in one week on March
10–12 in Turin, Italy.

The event is expected to draw over 2,000 high-level executives from pharma,
biotech, venture capital firms, and service companies who will be coming to
Turin to engage in one-to-one partnering meetings with innovative biotech
startups. Delegates are expected to engage in over 11,000 partnering meetings
at the event in just three days.

Monday’s Opening Plenary, entitled “Are big biotechs the better dealmakers?,”
will be moderated by Barclay James Kamb of Cooley LLP with heavy-hitter
panelists David Colpman of Shire; John F. McDonald of Biogen Idec; James Sabry
of Genentech; and Jeremy Springhorn of Alexion Pharmaceuticals, Inc.

“The life science dealmaking landscape is constantly adapting to change, and
one key trend is the emergence of big biotech as aggressive acquirers of third
party drugs. Companies such as Biogen Idec, Gilead and Celgene have built
significant value on the back of their dealmaking,” said David Colpman, Head
of Global Business Development at Shire. “But are these type of companies
better dealmakers, and what do we mean when we say ‘better?’ I think by
defining the benchmarks of success we will find the answer, and I look forward
to discussion toward that end at BIO-Europe Spring.”

The Monday afternoon parallel panel discussion on Immunotherapies, entitled
“From pariah to darling: Biopharma finally courts immunotherapies,” is
expected to be a big draw as immuno-oncology has quickly become the most
talked about approach for changing the treatment paradigm of cancer. This
panel will be moderated by Jeffrey M. Bockman of Defined Health, with global
research heads on the panel including Paul G. Higham of immatics
biotechnologies; Axel Hoos of GlaxoSmithKline; Hy Levitsky of Roche; Myra
Patchen of Biothera; and Helen Sabzevari of EMD Serono.

Academia has recently risen to a more prominent role in biopharma partnering,
and will be the feature of another Monday panel entitled “Final exams: When
academic science is called on to prove its value.” The panel will be moderated
by social media guru Steve Dickman of CBT Advisors, with panelists Elena
Beltrami of Fondazione Telethon; Diane Harbison of University of Edinburgh;
Werner Lanthaler of Evotec; and Chris Stahl of Cincinnati Children's Hospital
Medical Center discussing the role of technology transfer offices in early
stage biotech innovation.

“The increasing interaction of technology transfer offices with early-stage
biotech investors can be challenging in replicating and providing the sheer
volume of necessary benchmarks to show patient outcomes, and commercialization
potential of their novel compounds and technologies,” said Diane Harbison,
Head of Business Development, Edinburgh BioQuarter at University of Edinburgh.
“The panel aims to shed light on how TTOs are dealing with these interactions
and what types of models are working best.”

There will also be an Academic Innovators™ Showcase presentation track on
Tuesday morning with presentations by Cincinnati Children's Hospital Medical
Center; Edinburgh BioQuarter; Fondazione Istituto Italiano di Tecnologia;
Jagiellonian University; MicroMarine Biotech - Universidad de Valparaíso;
TTFactor srl; and University of Trieste - Department of Life Sciences.

The full program features executives speaking on industry topics relevant to
dealmaking and business development, and research trends, including orphan
diseases, funding drug discovery, personalized medicine, gene therapies,
immunotherapies and autoimmune disease, relevance data, regulatory issues, and
more.

BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship life
science partnering conference, BIO-Europe®. Companies participate in
one-to-one partnering meetings facilitated by EBD Group’s highly reputable
partneringONE® platform.

Register now for BIO-Europe Spring 2014, and read the Spotlight on Turin page
to plan your trip. Log onto partnering360® to join the BIO-Europe Spring 2014
Discussion Forum for event related news and discussion.

About the Regional Host Committee

BioEurope Spring is sponsored by the Torino Chamber of Commerce and is host
within the framework of Piemonte Health & Wellness, a project funded by
Regione Piemonte, Unioncamere Piemonte and the local Chambers of Commerce and
managed by Piemonte Agency with the support of the bioPmed innovation cluster.
The project provides international players the shortest way to meet and start
business with a selection of top class companies from Torino-Piemonte active
in the life sciences fields.

The Team’s assistance is completely free-of-charge: it ascertains
international players’ needs and upon request suggests possible suppliers and
arranges matchmaking activities. Member companies, selected on the basis of
strict and objective evaluation parameters, are all eager to face the
challenge of international markets and advanced technology.

About BIO-Europe Spring® 2014:

As the springtime counterpart to BIO-Europe^®, BIO-Europe Spring^® continues
the tradition of providing life science companies with high caliber partnering
opportunities. Featuring EBD Group’s acclaimed partnering system,
partneringONE^®, the event enables delegates to efficiently identify, meet and
get partnerships started with companies across the biotech value chain.

In addition to productive partnering, BIO-Europe Spring offers high level
workshops, panels, company presentations, and a lively exhibition. The program
features executive level panelists who openly share their insight and opinion
on many important industry issues. The company presentation tracks provide a
forum for innovative start-ups, established biotech companies, and large and
midsize pharma to present information on products, partnering opportunities
and corporate strategy.

Combined, these elements create an insightful and productive event that will
have you coming back year after year.

BIO-Europe Spring is produced by EBD Group, the leading partnering firm for
the global biotechnology industry, with the support of the Biotechnology
Industry Organization (BIO).

Follow BIO-Europe Spring 2014 on Twitter: twitter.com/ebdgroup (hashtag:
#BES14). Or log on to the BIO-Europe Spring 2014 Discussion Forum on
partnering360®. The Group is your go-to discussion forum for news and topics
related to BIO-Europe Spring.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry.
Since 1993, biotech, pharma and medical device companies have leveraged EBD
Group’s partnering conferences, technology and services to identify business
opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and
international trade associations and include:

  *BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science
    partnering conferences, supported by the Biotechnology Industry
    Organization (BIO)
  *BioPharm America™, the fastest growing partnering event in North America
  *Biotech Showcase™, a unique forum in San Francisco for presenting to
    investors and business development executives, co-produced with
    Demy-Colton Life Science Advisors
  *BioEquity Europe, the investor conference co-organized with BioCentury
    Publications and BIO
  *ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering
    conference in China, co-produced with ChinaBio® LLC
  *EuroMedtech™, EBD Group’s partnering event for the innovative medical
    technology industry
  *The Global Impact Forum, a unique and innovative partnering conference in
    impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is
used as the partnering engine at numerous third-party events around the world,
and partnering360® is the open online community of life science dealmakers
that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned
organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140303005331/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50815112&lang=en

Contact:

EBD Group
Erin Righetti, +1-760-930-0500
erighetti@ebdgroup.com
 
Press spacebar to pause and continue. Press esc to stop.